Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220008116 220020458 1.55 null Palliative (P) 2014-03-04 2014-03-04 RAVVA TRIAL 02 N 220033856 RAVVA TRIAL
220008117 220020458 1.7 54.2 Palliative (P) 2017-05-11 2017-05-31 ECX N N 220033856 ECX
220008118 220020458 null null Curative (C) 2016-02-05 2016-03-17 Cytarabine High Dose N N 220033856 CYTARABINE HIGH DOSE
220008119 220003251 1.65 null Palliative (P) 2013-01-20 2013-01-23 FLUOROURACIL + OXALIPLATIN N N 220033862 OXALIPLATIN + MDG
220008120 220003252 1.65 84.6 Palliative (P) 2014-07-15 2014-07-20 ECX 02 Y 220033863 ECX
220008121 220003252 1.9 70 Palliative (P) null 2017-11-22 Carboplatin + Etoposide iv&po N Y 220033863 CARBOPLATIN + ETOPOSIDE
220008122 220003253 1.5 72.1 Not known (9) 2017-05-12 2017-05-12 Carboplatin + Etoposide IV 3 day 02 N 220033868 CARBOPLATIN + ETOPOSIDE
220008123 220003253 1.75 null Neo-adjuvant (N) 2014-05-08 2014-05-15 PEMBROLIZUMAB Y N 220033868 RITUXIMAB
220008124 220003253 1.6 56.4 Palliative (P) null 2014-03-31 ECX N N 220033868 ECX
220008125 220003253 null 95 Palliative (P) 2016-01-03 2016-01-03 Oxaliplatin + Modified de Gramont N N 220033868 OXALIPLATIN + MDG
220008126 220020459 1.61 89 Curative (C) 2014-05-13 2014-05-13 AML Int Guide ADE 10+3+5 (1) N N 220033873 ADE
220008127 220020459 1.54 null Palliative (P) 2017-12-07 2017-12-07 EOX N N 220033873 EOX
220008128 220020459 1.7 null Palliative (P) null 2016-11-07 Oxaliplatin + Modified de Gramont null null 220033873 OXALIPLATIN + MDG
220008129 220022024 1.6 78.6 Palliative (P) 2013-12-14 2013-12-26 Carboplatin + Etoposide iv&po 2 Y 220033878 CARBOPLATIN + ETOPOSIDE
220008130 220003254 1.6 69 Palliative (P) 2017-12-06 2017-12-06 GEMCITABINE N N 220033879 GEMCITABINE
220008131 220003254 0 78.1 Curative (C) 2017-08-01 2017-08-15 Alemtuz+Fludara+Melphalan RIC MUD N N 220033879 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220008132 220003254 1.71 73 Adjuvant (A) 2016-04-22 2016-06-24 Cisplatin 100 + RT(H&N) 1 day 02 Y 220033879 CISPLATIN + RT
220008133 220003254 1.54 77.8 Palliative (P) 2015-02-13 2015-03-07 EOX 02 N 220033879 EOX
220008134 220020460 1.62 53.2 Palliative (P) null 2016-09-04 EOX N N 220033890 EOX
220008135 220003255 1.81 80.9 Disease modification (D) 2012-10-15 2013-02-24 Cytarabine High Dose N N 220033893 CYTARABINE HIGH DOSE
220008136 220003256 1.84 null null 2015-12-20 2016-02-24 Rituximab 2 N 220033896 RAVVA TRIAL
220008137 220003257 null 13.4 Palliative (P) 2015-03-10 2015-03-26 EOX N N 220033898 EOX
220008138 220011800 1.6 80.4 Palliative (P) 2017-12-04 2017-12-04 Carboplatin + Etoposide IV 3 day 02 N 220033903 CARBOPLATIN + ETOPOSIDE
220008139 220003258 1.64 77.8 Palliative (P) 2015-10-06 2015-10-23 EOX N N 220033904 EOX
220008140 220003259 null null Curative (C) 2014-11-15 2014-11-15 AML Int Guide ADE 10+3+5 (1) N null 220033910 ADE
220008141 220011801 1.78 97.4 Curative (C) 2013-06-10 2013-07-19 ADE N N 220033911 ADE
220008142 220011801 1.56 12.5 Palliative (P) 2015-08-07 2015-08-14 ECX N N 220033911 ECX
220008143 220011801 1.7 56 Curative (C) 2014-03-14 2014-03-14 ADE 10+3+5 01 N 220033911 ADE
220008144 220003260 1.65 92 Disease modification (D) null 2015-12-30 PEMBROLIZUMAB N N 220033923 PEMBROLIZUMAB
220008145 220003260 0 84 Curative (C) 2015-10-15 2015-10-16 Alemtuz+Fludara+Melphalan RIC MUD N N 220033923 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220008149 220003262 1.63 null Palliative (P) 2017-08-22 2017-09-05 EOX 2 N 220033933 EOX
220008150 220003263 1.72 null Palliative (P) 2015-02-19 2015-02-19 PEMBROLIZUMAB 02 N 220033934 RAVVA TRIAL
220008151 220003264 1.6 null Curative (C) null 2017-07-29 Cytarabine High Dose Y N 220033935 CYTARABINE HIGH DOSE
220008152 220011804 1.57 68 Neo-adjuvant (N) 2015-04-08 2015-04-08 RAVVA TRIAL 02 N 220033937 GEMCITABINE
220008153 220011804 1.8 70 Adjuvant (A) 2017-03-31 2017-05-02 CISPLATIN + RT N N 220033937 CISPLATIN + RT
220008154 220011804 1.65 8.8 Curative (C) null 2014-09-08 AML Int Guide ADE 10+3+5 (1) N N 220033937 ADE
220008155 220011804 1.5 54.5 Disease modification (D) 2014-09-01 2014-09-02 Cisplatin + Radiotherapy N N 220033937 CISPLATIN + RT
220008156 220003265 1.71 96 Not known (9) 2015-02-26 2015-02-26 RAVVA TRIAL N null 220033944 GEMCITABINE
220008157 220003266 1.7 74 Curative (C) 2014-11-16 2014-11-16 Cytarabine High Dose null null 220033949 CYTARABINE HIGH DOSE
220008158 220003266 1.75 78.8 Curative (C) 2013-10-28 2013-10-30 FLAG N N 220033949 FLAG
220008159 220003267 1.64 44.9 Not known (9) 2015-07-11 2015-07-11 EOX N N 220033952 EOX
220008160 220003268 1.71 78.8 Curative (C) null 2015-05-16 Cisplatin + Radiotherapy + CISPLATIN N N 220033953 CISPLATIN + RT
220008161 220011806 1.55 53 Palliative (P) 2013-06-23 2013-06-29 EOX N N 220033955 EOX
220008162 220011806 null 89 Palliative (P) 2013-09-04 2013-09-15 Carboplatin + Etoposide iv&po N N 220033955 CARBOPLATIN + ETOPOSIDE
220008163 220011806 1.52 null Palliative (P) 2013-06-12 2013-06-25 Oxaliplatin + Modified de Gramont N N 220033955 OXALIPLATIN + MDG
220008164 220011806 1.28 68.3 Palliative (P) 2013-11-28 2013-12-11 Oxaliplatin + Modified de Gramont N N 220033955 OXALIPLATIN + MDG
220008165 220011806 1.62 50.15 Palliative (P) 2016-04-13 2016-04-26 Carboplatin AUC 2 - 5 N null 220033955 CARBOPLATIN
220008166 220011806 1.62 null Palliative (P) null 2016-02-05 RAVVA TRIAL 02 N 220033955 PEMBROLIZUMAB
220008167 220003269 1.65 95.8 Adjuvant (A) 2017-05-24 2017-05-25 CISPLATIN + RT N null 220033971 CISPLATIN + RT
220008168 220003270 1.84 null Curative (C) 2015-11-10 2015-11-11 AML Int Guide HD Cytarabine (3 + 4) 1 N 220033972 CYTARABINE HIGH DOSE